Have you seen CD30+ lymphoproliferative skin lesions with Upadacitinib treatment of atopic dermatitis?

I have seen this occur in the setting of atopic dermatitis in one instance with a patient on dupilumab who developed head and neck CD30+ disease. It is certainly possible with upadacitinib but I think most if not all cases of CTCL in the setting of AD were always CTCL from the beginning and just mis...